Sherwood Therapeutics
 
 
Developing novel wound care products
 
Home
Management Contact:

Chairman - Michael Elves LLB PhD DSc FRCPath

Previously Director of Cellular Sciences, Glaxo; Director of Scientific and Educational Affairs, Glaxo Wellcome; Specialist Advisor to the House of Commons Science and Technology Select Committee.

Chief Executive Officer - Nigel Davis PhD MBA

Previously at Glaxo; Managing Director of Innovir UK; Isis Innovations; Head of Transactions at PharmaVentures; currently CBO Cambridge Theranostics; NED Ploughshare Innovations, Sivaden.

Chief Technical Officer - David Pritchard PhD

Founder and key inventor; Professor of Parasite Immunology, University of Nottingham School of Pharmacy.

Director - Andrew Tulloch PhD MBA

CEO Ploughshare Innovations and Director of several start-up technology companies.

CEO

Dr Nigel Davis

Tel: 07711 983344

email: nigel.davis@

sherwoodtherapeutics.com